Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Neurooncol. 2014 Dec 13;121(3):627–634. doi: 10.1007/s11060-014-1680-2

Fig. 1.

Fig. 1

Overall survival. Kaplan–Meier survival curve for all patients having received at least one dose of vandetanib and sirolimus at the maximum tolerated dose